It was concerning to read Henry and colleagues' study on the poor adherence to pregnancy
prevention while women are taking isotretinoin. 1 This drug was first licensed in 1982 in the …

BACKGROUND Isotretinoin is a known human teratogen, causing birth defects and/or
subnormal cognitive performance in prenatally‐exposed children. METHODS A survey was …

Information Services had the labelled indication. Moreover, although the drug was originally
intended to be prescribed by dermatologists, many family physicians now prescribe it. Of the …

(1) Background: Isotretinoin (ISO) is a systemic retinoid known for its teratogenic effects on
embryos and fetuses. The aim of this study was to compare the pregnancy outcomes of …

Objective. We aimed to study the pregnancy outcomes of women exposed to isotretinoin and
to identify the factors influencing their decision to request an abortion. Methods. The study …

Isotretinoin is known as a potent teratogenic agent. Pregnancy should be ruled out before
isotretinoin is prescribed. In this study, we evaluated the fetal outcomes of pregnant women …

The prescription of known teratogenic medications requires a careful balance between
allowing women access to medications that they might need and avoiding unnecessary …

Objective Apart from thalidomide, retinoids like isotretinoin are the strongest teratogens in
humans known today. The overall risk of birth defects is estimated as up to 30% after …

BACKGROUND: Isotretinoin is a known teratogen. Pregnancy prevention programs aimed at
minimizing isotretinoin exposure in pregnancy have been implemented in North America …

Discussion Our patient did not have an anamnesis of consanguineous marriage or
gestational diabetes. There was consent that the infant's phenotype along with the maternal …